{"id":198022,"date":"2024-10-19T12:36:26","date_gmt":"2024-10-19T12:36:26","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-18242-2016\/"},"modified":"2024-10-25T05:09:40","modified_gmt":"2024-10-25T05:09:40","slug":"aami-18242-2016","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-18242-2016\/","title":{"rendered":"AAMI 18242 2016"},"content":{"rendered":"
Specifies requirements for sterile, single-use, extracorporeal centrifugal blood pumps, whether coated, non-surface modified, or surface-modified, intended for producing blood flow during extracorporeal circulation.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | ANSI\/AAMI\/ISO 18242:2016; Cardiovascular implants and extracorporeal systems\u2014Centrifugal blood pumps <\/td>\n<\/tr>\n | ||||||
2<\/td>\n | Objectives and uses of AAMI standards andrecommended practices <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title page <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | AAMI Standard Copyright information <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Contents Page <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Glossary of equivalent standards <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Committee representation <\/td>\n<\/tr>\n | ||||||
8<\/td>\n | Background of AAMI adoption of ISO 18242:2016 <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 1 Scope 2 Normative references <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 4 Requirements 4.1 Biological characteristics 4.1.1 Sterility and non-pyrogenicity 4.1.2 Biocompatibility 4.2 Physical characteristics 4.2.1 Blood pathway integrity 4.2.2 Prime volume 4.2.3 Connector integrity 4.3 Performance characteristics 4.3.1 Hydraulic performance 4.3.2 Blood cell damage <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 4.3.2.1 Plasma-free hemoglobin 4.3.2.2 Platelet reduction 4.3.2.3 White blood cell reduction 4.3.3 Bearing durability 4.3.4 Shelf life 5 Tests and measurements to determine compliance with this document 5.1 General 5.1.1 Tests and measurements 5.1.2 Operating variables 5.1.3 Temperature 5.1.4 Relationship between variables 5.1.5 Procedures <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 5.1.6 Driver\/console 5.2 Biological characteristics 5.2.1 Sterility and non-pyrogenicity 5.2.2 Biocompatibility 5.3 Physical characteristics 5.3.1 Blood pathway integrity 5.3.1.1 Test liquid 5.3.1.2 Procedure 5.3.2 Prime volume 5.3.2.1 Test liquid 5.3.2.2 Procedure 5.3.3 Connectors 5.3.3.1 Procedure <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 5.4 Performance characteristics 5.4.1 Hydraulic performance 5.4.1.1 Test liquid 5.4.1.2 Procedure 5.4.2 Blood cell damage 5.4.2.1 Test liquid 5.4.2.2 Procedure Table 1 \u2014 Conditions for in vitro testing of blood cell damage <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | Table 2 \u2014 Sampling schedule 5.4.3 Bearing wear 5.4.3.1 Test liquid 5.4.3.2 Procedure 5.4.4 Shelf life 6 Information supplied by the manufacturer 6.1 Information on the device <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | 6.2 Information on the packaging 6.2.1 Unit container 6.2.2 Shipping container 6.3 Information in the accompanying documents <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 6.4 Information in the accompanying documents in a prominent form 7 Packaging <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" ANSI\/AAMI\/ISO 18242:2016 – Cardiovascular implants and extracorporeal systems-Centrifugal blood pumps<\/b><\/p>\n |